David Murphy
Concepts (345)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Intensive Care Units | 25 | 2025 | 848 | 3.990 |
Why?
| | Critical Care | 9 | 2025 | 616 | 2.110 |
Why?
| | Critical Illness | 13 | 2025 | 805 | 2.080 |
Why?
| | Erythrocyte Transfusion | 6 | 2019 | 197 | 2.070 |
Why?
| | Health Resources | 3 | 2016 | 124 | 1.290 |
Why?
| | Pneumonia, Ventilator-Associated | 2 | 2018 | 53 | 1.030 |
Why?
| | Delphi Technique | 3 | 2025 | 278 | 0.970 |
Why?
| | Sepsis | 8 | 2024 | 601 | 0.930 |
Why?
| | Common Data Elements | 1 | 2025 | 14 | 0.920 |
Why?
| | Wounds and Injuries | 3 | 2025 | 758 | 0.910 |
Why?
| | Cross Infection | 3 | 2019 | 249 | 0.840 |
Why?
| | Hospital Mortality | 10 | 2025 | 911 | 0.780 |
Why?
| | Multiple Organ Failure | 3 | 2019 | 123 | 0.770 |
Why?
| | Brain Diseases | 4 | 2024 | 145 | 0.740 |
Why?
| | Organ Dysfunction Scores | 3 | 2020 | 49 | 0.740 |
Why?
| | Fluid Therapy | 3 | 2024 | 134 | 0.720 |
Why?
| | Neurodevelopmental Disorders | 4 | 2025 | 182 | 0.720 |
Why?
| | Computed Tomography Angiography | 3 | 2017 | 130 | 0.710 |
Why?
| | Bacterial Infections | 2 | 2021 | 244 | 0.670 |
Why?
| | Radiation Dosage | 2 | 2020 | 188 | 0.630 |
Why?
| | Health Care Costs | 3 | 2020 | 414 | 0.620 |
Why?
| | Survivors | 1 | 2023 | 499 | 0.600 |
Why?
| | Movement Disorders | 3 | 2024 | 64 | 0.590 |
Why?
| | Coronary Artery Disease | 4 | 2019 | 698 | 0.590 |
Why?
| | Drug Resistance, Multiple, Bacterial | 1 | 2019 | 74 | 0.590 |
Why?
| | Coronary Angiography | 3 | 2017 | 318 | 0.590 |
Why?
| | Systemic Inflammatory Response Syndrome | 2 | 2022 | 95 | 0.570 |
Why?
| | Humans | 79 | 2025 | 137601 | 0.550 |
Why?
| | Ventilators, Mechanical | 2 | 2020 | 59 | 0.550 |
Why?
| | Ventricular Outflow Obstruction | 1 | 2017 | 40 | 0.540 |
Why?
| | Blood Transfusion | 2 | 2018 | 337 | 0.530 |
Why?
| | Mitral Valve Insufficiency | 1 | 2017 | 67 | 0.530 |
Why?
| | Mitral Valve | 1 | 2017 | 89 | 0.530 |
Why?
| | Hip Fractures | 1 | 2018 | 85 | 0.520 |
Why?
| | Hemoglobins | 6 | 2019 | 352 | 0.510 |
Why?
| | Practice Patterns, Physicians' | 3 | 2021 | 1299 | 0.510 |
Why?
| | Respiration, Artificial | 3 | 2021 | 639 | 0.500 |
Why?
| | Physician Incentive Plans | 1 | 2016 | 7 | 0.490 |
Why?
| | United States Public Health Service | 1 | 2015 | 10 | 0.490 |
Why?
| | Albumins | 1 | 2016 | 115 | 0.480 |
Why?
| | Pneumonia, Viral | 4 | 2020 | 369 | 0.470 |
Why?
| | Heart Valve Prosthesis Implantation | 1 | 2017 | 173 | 0.470 |
Why?
| | Intellectual Disability | 4 | 2025 | 165 | 0.450 |
Why?
| | Hospitals | 2 | 2020 | 691 | 0.450 |
Why?
| | Phenotype | 10 | 2025 | 3150 | 0.450 |
Why?
| | Emergencies | 1 | 2015 | 168 | 0.440 |
Why?
| | Radiology | 1 | 2017 | 177 | 0.440 |
Why?
| | Lung Diseases | 2 | 2024 | 768 | 0.440 |
Why?
| | Cardiac Catheterization | 1 | 2017 | 514 | 0.430 |
Why?
| | Middle Aged | 29 | 2025 | 33441 | 0.430 |
Why?
| | Cardiomyopathies | 1 | 2017 | 322 | 0.410 |
Why?
| | Developmental Disabilities | 3 | 2024 | 268 | 0.410 |
Why?
| | Guideline Adherence | 3 | 2016 | 551 | 0.400 |
Why?
| | Emergency Medical Services | 2 | 2016 | 559 | 0.390 |
Why?
| | Spastic Paraplegia, Hereditary | 2 | 2022 | 12 | 0.390 |
Why?
| | Catheter-Related Infections | 2 | 2010 | 89 | 0.380 |
Why?
| | Microcephaly | 2 | 2024 | 99 | 0.380 |
Why?
| | Female | 36 | 2025 | 73359 | 0.380 |
Why?
| | Quality Improvement | 3 | 2020 | 1180 | 0.370 |
Why?
| | Data Collection | 1 | 2015 | 660 | 0.370 |
Why?
| | Catheterization, Central Venous | 2 | 2010 | 113 | 0.370 |
Why?
| | Evidence-Based Medicine | 2 | 2013 | 739 | 0.360 |
Why?
| | Evidence-Based Practice | 1 | 2014 | 232 | 0.360 |
Why?
| | Hospitalization | 7 | 2022 | 2197 | 0.360 |
Why?
| | Male | 34 | 2025 | 67690 | 0.350 |
Why?
| | Coronavirus Infections | 3 | 2020 | 367 | 0.350 |
Why?
| | Mitochondrial Diseases | 2 | 2022 | 91 | 0.350 |
Why?
| | Societies, Hospital | 1 | 2010 | 1 | 0.340 |
Why?
| | Tomography, X-Ray Computed | 4 | 2024 | 2679 | 0.330 |
Why?
| | Water-Electrolyte Imbalance | 2 | 2025 | 44 | 0.330 |
Why?
| | Aged | 20 | 2025 | 23938 | 0.320 |
Why?
| | Consensus | 3 | 2025 | 673 | 0.310 |
Why?
| | Retrospective Studies | 17 | 2025 | 15720 | 0.300 |
Why?
| | Epilepsy | 2 | 2023 | 335 | 0.300 |
Why?
| | Aged, 80 and over | 8 | 2021 | 7609 | 0.300 |
Why?
| | Personnel Staffing and Scheduling | 1 | 2009 | 97 | 0.290 |
Why?
| | Delivery of Health Care | 1 | 2015 | 952 | 0.270 |
Why?
| | Betacoronavirus | 2 | 2020 | 270 | 0.270 |
Why?
| | Hospital Costs | 2 | 2019 | 118 | 0.260 |
Why?
| | Electronic Health Records | 5 | 2024 | 1073 | 0.250 |
Why?
| | Acute Lung Injury | 1 | 2009 | 285 | 0.240 |
Why?
| | Maryland | 2 | 2018 | 59 | 0.240 |
Why?
| | Length of Stay | 3 | 2025 | 1210 | 0.230 |
Why?
| | Mediator Complex | 2 | 2023 | 61 | 0.230 |
Why?
| | Quality of Health Care | 3 | 2021 | 649 | 0.230 |
Why?
| | Adult | 19 | 2025 | 37910 | 0.230 |
Why?
| | Unsupervised Machine Learning | 1 | 2025 | 22 | 0.220 |
Why?
| | Pneumonia | 2 | 2010 | 638 | 0.220 |
Why?
| | Medication Therapy Management | 1 | 2025 | 75 | 0.220 |
Why?
| | Patient Satisfaction | 1 | 2009 | 677 | 0.220 |
Why?
| | Infection Control | 3 | 2018 | 163 | 0.220 |
Why?
| | United States | 14 | 2021 | 14925 | 0.220 |
Why?
| | Coronary Vessels | 2 | 2016 | 245 | 0.210 |
Why?
| | Resuscitation | 2 | 2024 | 238 | 0.210 |
Why?
| | Intra-Abdominal Fat | 1 | 2024 | 90 | 0.210 |
Why?
| | Congenital Disorders of Glycosylation | 1 | 2023 | 13 | 0.210 |
Why?
| | Epilepsy, Generalized | 1 | 2023 | 19 | 0.210 |
Why?
| | Nervous System Malformations | 1 | 2024 | 43 | 0.210 |
Why?
| | Continuous Positive Airway Pressure | 1 | 2024 | 92 | 0.210 |
Why?
| | Cysts | 1 | 2024 | 115 | 0.210 |
Why?
| | Adaptor Proteins, Vesicular Transport | 1 | 2023 | 45 | 0.210 |
Why?
| | Membrane Transport Proteins | 1 | 2024 | 150 | 0.200 |
Why?
| | Positron Emission Tomography Computed Tomography | 3 | 2024 | 100 | 0.200 |
Why?
| | Systems Analysis | 1 | 2023 | 23 | 0.200 |
Why?
| | Glucagon-Like Peptide 1 | 1 | 2024 | 134 | 0.200 |
Why?
| | Abnormalities, Multiple | 1 | 2024 | 195 | 0.200 |
Why?
| | Pharmacists | 2 | 2022 | 262 | 0.190 |
Why?
| | Cell Division | 1 | 2024 | 790 | 0.190 |
Why?
| | Information Dissemination | 1 | 2025 | 225 | 0.190 |
Why?
| | Dystonia | 1 | 2022 | 26 | 0.190 |
Why?
| | Neural Stem Cells | 1 | 2024 | 156 | 0.190 |
Why?
| | Apyrase | 1 | 2022 | 18 | 0.190 |
Why?
| | Connective Tissue Diseases | 1 | 2022 | 84 | 0.180 |
Why?
| | Severity of Illness Index | 4 | 2021 | 2840 | 0.180 |
Why?
| | beta Karyopherins | 1 | 2021 | 8 | 0.180 |
Why?
| | Induced Pluripotent Stem Cells | 1 | 2024 | 248 | 0.180 |
Why?
| | Pharmacy | 1 | 2021 | 34 | 0.180 |
Why?
| | Community Pharmacy Services | 1 | 2021 | 46 | 0.180 |
Why?
| | Loss of Heterozygosity | 1 | 2021 | 51 | 0.180 |
Why?
| | Loss of Function Mutation | 1 | 2021 | 46 | 0.170 |
Why?
| | Calcium-Binding Proteins | 1 | 2022 | 214 | 0.170 |
Why?
| | Pharmaceutical Services | 1 | 2021 | 85 | 0.170 |
Why?
| | Cataract | 1 | 2023 | 219 | 0.170 |
Why?
| | Cannula | 1 | 2020 | 20 | 0.170 |
Why?
| | Pharmacy Service, Hospital | 1 | 2021 | 88 | 0.170 |
Why?
| | Neurodegenerative Diseases | 1 | 2022 | 138 | 0.170 |
Why?
| | Pneumonia, Bacterial | 1 | 2021 | 114 | 0.170 |
Why?
| | Mutation | 7 | 2025 | 3991 | 0.160 |
Why?
| | Health Care Surveys | 2 | 2014 | 562 | 0.160 |
Why?
| | Retinal Diseases | 1 | 2021 | 96 | 0.160 |
Why?
| | White Matter | 1 | 2022 | 143 | 0.160 |
Why?
| | Coinfection | 1 | 2021 | 138 | 0.160 |
Why?
| | Sleep Apnea, Obstructive | 1 | 2024 | 302 | 0.160 |
Why?
| | Immunomodulation | 1 | 2020 | 99 | 0.160 |
Why?
| | Medical Overuse | 1 | 2020 | 32 | 0.160 |
Why?
| | Cardiovascular Surgical Procedures | 1 | 2019 | 30 | 0.160 |
Why?
| | Urinalysis | 1 | 2020 | 77 | 0.160 |
Why?
| | DNA, Mitochondrial | 1 | 2021 | 208 | 0.160 |
Why?
| | Child, Preschool | 9 | 2025 | 11102 | 0.160 |
Why?
| | Hematocrit | 1 | 2019 | 102 | 0.160 |
Why?
| | Nuclear Proteins | 1 | 2024 | 708 | 0.160 |
Why?
| | Quality Assurance, Health Care | 3 | 2010 | 326 | 0.160 |
Why?
| | Aortic Aneurysm, Thoracic | 1 | 2021 | 134 | 0.150 |
Why?
| | DNA Methylation | 1 | 2024 | 637 | 0.150 |
Why?
| | Artificial Intelligence | 1 | 2023 | 291 | 0.150 |
Why?
| | Socioenvironmental Therapy | 1 | 2019 | 2 | 0.150 |
Why?
| | Subarachnoid Hemorrhage | 1 | 2019 | 67 | 0.150 |
Why?
| | Oxygen Inhalation Therapy | 1 | 2020 | 161 | 0.150 |
Why?
| | Economics, Hospital | 1 | 2019 | 28 | 0.150 |
Why?
| | Weight Loss | 1 | 2024 | 785 | 0.150 |
Why?
| | Academic Medical Centers | 3 | 2022 | 506 | 0.140 |
Why?
| | Gastrointestinal Hemorrhage | 1 | 2019 | 134 | 0.140 |
Why?
| | Diagnostic Techniques and Procedures | 1 | 2018 | 21 | 0.140 |
Why?
| | Clinical Protocols | 2 | 2017 | 268 | 0.140 |
Why?
| | New Jersey | 1 | 2018 | 16 | 0.140 |
Why?
| | Intubation, Intratracheal | 1 | 2020 | 259 | 0.140 |
Why?
| | Kentucky | 1 | 2018 | 39 | 0.140 |
Why?
| | Nervous System Diseases | 1 | 2021 | 272 | 0.140 |
Why?
| | Anemia | 1 | 2019 | 172 | 0.140 |
Why?
| | Medical Audit | 2 | 2017 | 76 | 0.140 |
Why?
| | Nutrition Assessment | 1 | 2018 | 92 | 0.140 |
Why?
| | Bacteremia | 2 | 2010 | 214 | 0.140 |
Why?
| | Acute Coronary Syndrome | 2 | 2019 | 281 | 0.140 |
Why?
| | Plasma | 1 | 2019 | 217 | 0.140 |
Why?
| | Randomized Controlled Trials as Topic | 3 | 2024 | 1468 | 0.140 |
Why?
| | Clinical Decision-Making | 1 | 2021 | 329 | 0.140 |
Why?
| | Shock, Hemorrhagic | 1 | 2019 | 167 | 0.140 |
Why?
| | Washington | 1 | 2018 | 158 | 0.140 |
Why?
| | Hematologic Neoplasms | 1 | 2019 | 157 | 0.140 |
Why?
| | Urinary Tract Infections | 1 | 2020 | 191 | 0.140 |
Why?
| | Hospitals, University | 1 | 2017 | 179 | 0.130 |
Why?
| | Preoperative Period | 1 | 2017 | 135 | 0.130 |
Why?
| | Infant | 7 | 2025 | 9539 | 0.130 |
Why?
| | Prospective Studies | 4 | 2016 | 7580 | 0.130 |
Why?
| | Pedigree | 3 | 2022 | 511 | 0.130 |
Why?
| | Risk Factors | 5 | 2021 | 10319 | 0.130 |
Why?
| | Tomography Scanners, X-Ray Computed | 1 | 2016 | 19 | 0.130 |
Why?
| | Quality Indicators, Health Care | 1 | 2019 | 306 | 0.130 |
Why?
| | Drug Utilization Review | 1 | 2016 | 55 | 0.120 |
Why?
| | Cost Savings | 1 | 2016 | 84 | 0.120 |
Why?
| | Arteritis | 1 | 2016 | 27 | 0.120 |
Why?
| | Residence Characteristics | 1 | 2019 | 363 | 0.120 |
Why?
| | Fracture Fixation, Internal | 1 | 2018 | 192 | 0.120 |
Why?
| | Non-alcoholic Fatty Liver Disease | 1 | 2019 | 279 | 0.120 |
Why?
| | Heart Neoplasms | 1 | 2015 | 52 | 0.120 |
Why?
| | Arthroplasty, Replacement, Hip | 1 | 2018 | 177 | 0.120 |
Why?
| | Burns | 1 | 2019 | 335 | 0.110 |
Why?
| | Respiratory Insufficiency | 2 | 2020 | 317 | 0.110 |
Why?
| | Adolescent | 9 | 2025 | 21435 | 0.110 |
Why?
| | Interdisciplinary Communication | 1 | 2015 | 185 | 0.110 |
Why?
| | Patient Outcome Assessment | 1 | 2015 | 130 | 0.110 |
Why?
| | Baltimore | 1 | 2014 | 55 | 0.110 |
Why?
| | Shock | 1 | 2015 | 97 | 0.110 |
Why?
| | Brain Injuries, Traumatic | 1 | 2019 | 372 | 0.110 |
Why?
| | Practice Guidelines as Topic | 3 | 2021 | 1541 | 0.100 |
Why?
| | Regression Analysis | 1 | 2016 | 1010 | 0.100 |
Why?
| | Health Services Needs and Demand | 1 | 2015 | 279 | 0.100 |
Why?
| | Medical Staff, Hospital | 1 | 2014 | 81 | 0.100 |
Why?
| | Time Factors | 3 | 2022 | 6818 | 0.100 |
Why?
| | Injury Severity Score | 1 | 2015 | 516 | 0.100 |
Why?
| | Carcinoma, Renal Cell | 1 | 2015 | 220 | 0.100 |
Why?
| | Child | 8 | 2025 | 21833 | 0.100 |
Why?
| | Prognosis | 2 | 2020 | 3966 | 0.100 |
Why?
| | Confidence Intervals | 1 | 2013 | 334 | 0.100 |
Why?
| | Age Factors | 2 | 2017 | 3253 | 0.100 |
Why?
| | Acidosis | 1 | 2013 | 101 | 0.100 |
Why?
| | Organizational Culture | 2 | 2010 | 150 | 0.100 |
Why?
| | Paraplegia | 2 | 2022 | 60 | 0.090 |
Why?
| | Anti-Bacterial Agents | 2 | 2020 | 1799 | 0.090 |
Why?
| | Cohort Studies | 4 | 2025 | 5691 | 0.090 |
Why?
| | Syndrome | 2 | 2024 | 376 | 0.090 |
Why?
| | Nursing Staff, Hospital | 1 | 2014 | 158 | 0.090 |
Why?
| | Pandemics | 4 | 2020 | 1627 | 0.090 |
Why?
| | Autoimmune Diseases | 1 | 2016 | 452 | 0.090 |
Why?
| | Young Adult | 6 | 2025 | 13203 | 0.090 |
Why?
| | Immunoglobulin G | 1 | 2016 | 902 | 0.090 |
Why?
| | Patient Discharge | 1 | 2018 | 901 | 0.090 |
Why?
| | Program Evaluation | 1 | 2016 | 909 | 0.090 |
Why?
| | Treatment Outcome | 3 | 2020 | 10813 | 0.090 |
Why?
| | Intensive Care Units, Pediatric | 1 | 2013 | 262 | 0.090 |
Why?
| | Kidney Neoplasms | 1 | 2015 | 403 | 0.090 |
Why?
| | Obesity | 1 | 2024 | 2985 | 0.090 |
Why?
| | APACHE | 2 | 2025 | 64 | 0.080 |
Why?
| | Odds Ratio | 1 | 2013 | 1074 | 0.080 |
Why?
| | Diet | 1 | 2018 | 1287 | 0.080 |
Why?
| | Checklist | 1 | 2010 | 96 | 0.080 |
Why?
| | Safety Management | 1 | 2010 | 123 | 0.080 |
Why?
| | Animals | 7 | 2025 | 37088 | 0.080 |
Why?
| | Zebrafish | 2 | 2024 | 500 | 0.070 |
Why?
| | Machine Learning | 2 | 2025 | 516 | 0.070 |
Why?
| | Cardiac Surgical Procedures | 1 | 2014 | 538 | 0.070 |
Why?
| | Medical Errors | 1 | 2009 | 112 | 0.070 |
Why?
| | Health Knowledge, Attitudes, Practice | 1 | 2016 | 1364 | 0.070 |
Why?
| | Lung | 1 | 2020 | 4057 | 0.070 |
Why?
| | Cardiovascular Diseases | 1 | 2019 | 2041 | 0.070 |
Why?
| | Brain | 3 | 2024 | 2725 | 0.070 |
Why?
| | Health Services Research | 1 | 2010 | 403 | 0.070 |
Why?
| | Workload | 1 | 2009 | 162 | 0.070 |
Why?
| | Biomarkers | 1 | 2018 | 4092 | 0.070 |
Why?
| | Membrane Proteins | 2 | 2024 | 1152 | 0.070 |
Why?
| | Decision Making | 1 | 2014 | 937 | 0.060 |
Why?
| | Emergency Service, Hospital | 1 | 2017 | 2093 | 0.060 |
Why?
| | Longitudinal Studies | 1 | 2013 | 2836 | 0.060 |
Why?
| | Oregon | 1 | 2025 | 74 | 0.060 |
Why?
| | Anti-Inflammatory Agents | 1 | 2008 | 473 | 0.060 |
Why?
| | Ethanolamine | 1 | 2024 | 6 | 0.060 |
Why?
| | Birt-Hogg-Dube Syndrome | 1 | 2024 | 8 | 0.060 |
Why?
| | Genes, Dominant | 1 | 2024 | 97 | 0.060 |
Why?
| | Genes, Recessive | 1 | 2024 | 78 | 0.050 |
Why?
| | Sodium-Phosphate Cotransporter Proteins, Type III | 1 | 2024 | 5 | 0.050 |
Why?
| | Glucocorticoids | 1 | 2008 | 528 | 0.050 |
Why?
| | Proof of Concept Study | 1 | 2024 | 84 | 0.050 |
Why?
| | Histiocytosis, Langerhans-Cell | 1 | 2024 | 36 | 0.050 |
Why?
| | Lymphangioleiomyomatosis | 1 | 2024 | 36 | 0.050 |
Why?
| | Guanine Nucleotide Exchange Factors | 1 | 2024 | 65 | 0.050 |
Why?
| | Receptors, Virus | 1 | 2024 | 94 | 0.050 |
Why?
| | Inheritance Patterns | 1 | 2024 | 44 | 0.050 |
Why?
| | Single-Blind Method | 1 | 2024 | 283 | 0.050 |
Why?
| | Propensity Score | 1 | 2025 | 307 | 0.050 |
Why?
| | Fluorodeoxyglucose F18 | 1 | 2024 | 135 | 0.050 |
Why?
| | Choline | 1 | 2024 | 131 | 0.050 |
Why?
| | ATP-Binding Cassette Transporters | 1 | 2024 | 120 | 0.050 |
Why?
| | Cell Polarity | 1 | 2024 | 140 | 0.050 |
Why?
| | Tremor | 1 | 2024 | 98 | 0.050 |
Why?
| | Acetylation | 1 | 2024 | 245 | 0.050 |
Why?
| | Glycosylation | 1 | 2023 | 161 | 0.050 |
Why?
| | Atrophy | 1 | 2023 | 188 | 0.050 |
Why?
| | Drosophila Proteins | 1 | 2025 | 202 | 0.050 |
Why?
| | Drosophila melanogaster | 1 | 2025 | 234 | 0.050 |
Why?
| | Phosphates | 1 | 2024 | 180 | 0.050 |
Why?
| | Vesicular Monoamine Transport Proteins | 1 | 2022 | 8 | 0.050 |
Why?
| | Spectrin | 1 | 2022 | 14 | 0.050 |
Why?
| | Neurogenesis | 1 | 2024 | 150 | 0.050 |
Why?
| | Amines | 1 | 2022 | 40 | 0.050 |
Why?
| | Dysarthria | 1 | 2022 | 10 | 0.050 |
Why?
| | Ataxia | 1 | 2022 | 70 | 0.050 |
Why?
| | Nervous System | 1 | 2022 | 67 | 0.050 |
Why?
| | Homozygote | 1 | 2022 | 203 | 0.050 |
Why?
| | Mice | 3 | 2024 | 17748 | 0.050 |
Why?
| | Immunoglobulins, Intravenous | 1 | 2022 | 129 | 0.050 |
Why?
| | Cerebellum | 1 | 2023 | 216 | 0.050 |
Why?
| | Cluster Analysis | 1 | 2023 | 512 | 0.040 |
Why?
| | Follow-Up Studies | 2 | 2021 | 5121 | 0.040 |
Why?
| | Alleles | 1 | 2024 | 886 | 0.040 |
Why?
| | Mortality | 2 | 2017 | 354 | 0.040 |
Why?
| | Repressor Proteins | 1 | 2024 | 423 | 0.040 |
Why?
| | Pulmonary Disease, Chronic Obstructive | 1 | 2008 | 1027 | 0.040 |
Why?
| | Time | 1 | 2020 | 88 | 0.040 |
Why?
| | Georgia | 1 | 2020 | 83 | 0.040 |
Why?
| | Dose-Response Relationship, Radiation | 1 | 2020 | 143 | 0.040 |
Why?
| | Radiotherapy Dosage | 1 | 2020 | 278 | 0.040 |
Why?
| | Pyuria | 1 | 2020 | 4 | 0.040 |
Why?
| | Disease Management | 1 | 2024 | 619 | 0.040 |
Why?
| | Professional Role | 1 | 2021 | 166 | 0.040 |
Why?
| | Mitochondrial Proteins | 1 | 2022 | 257 | 0.040 |
Why?
| | Morbidity | 1 | 2021 | 319 | 0.040 |
Why?
| | Diagnosis, Differential | 1 | 2024 | 1488 | 0.040 |
Why?
| | Catheters, Indwelling | 2 | 2010 | 89 | 0.040 |
Why?
| | Epigenesis, Genetic | 1 | 2024 | 646 | 0.040 |
Why?
| | Inappropriate Prescribing | 1 | 2020 | 57 | 0.040 |
Why?
| | Seizures | 1 | 2022 | 430 | 0.040 |
Why?
| | Caenorhabditis elegans | 1 | 2022 | 327 | 0.040 |
Why?
| | Safety | 1 | 2020 | 345 | 0.040 |
Why?
| | Homeostasis | 1 | 2022 | 616 | 0.040 |
Why?
| | Transforming Growth Factor beta | 1 | 2021 | 486 | 0.040 |
Why?
| | Fibroblasts | 1 | 2023 | 1000 | 0.040 |
Why?
| | Lung Diseases, Interstitial | 1 | 2024 | 641 | 0.030 |
Why?
| | Saccharomyces cerevisiae | 1 | 2022 | 552 | 0.030 |
Why?
| | Insurance Claim Reporting | 1 | 2017 | 26 | 0.030 |
Why?
| | Education, Distance | 1 | 2018 | 53 | 0.030 |
Why?
| | Clinical Coding | 1 | 2017 | 24 | 0.030 |
Why?
| | Societies, Medical | 1 | 2021 | 818 | 0.030 |
Why?
| | Mitochondria | 1 | 2022 | 950 | 0.030 |
Why?
| | Survival Rate | 1 | 2020 | 1906 | 0.030 |
Why?
| | Socioeconomic Factors | 1 | 2020 | 1303 | 0.030 |
Why?
| | RNA | 1 | 2022 | 926 | 0.030 |
Why?
| | Clinical Trials as Topic | 1 | 2020 | 1029 | 0.030 |
Why?
| | Population Surveillance | 1 | 2019 | 479 | 0.030 |
Why?
| | Comorbidity | 1 | 2020 | 1634 | 0.030 |
Why?
| | Interviews as Topic | 1 | 2018 | 802 | 0.030 |
Why?
| | Surveys and Questionnaires | 2 | 2018 | 5835 | 0.030 |
Why?
| | Coronary Artery Bypass | 1 | 2016 | 231 | 0.030 |
Why?
| | Mice, Knockout | 1 | 2021 | 3007 | 0.030 |
Why?
| | Disease Models, Animal | 1 | 2024 | 4301 | 0.030 |
Why?
| | Rats | 1 | 2022 | 5558 | 0.030 |
Why?
| | Algorithms | 1 | 2020 | 1701 | 0.020 |
Why?
| | Prevalence | 1 | 2019 | 2735 | 0.020 |
Why?
| | Research Design | 1 | 2018 | 1110 | 0.020 |
Why?
| | Hospital Administration | 1 | 2010 | 25 | 0.020 |
Why?
| | Incidence | 1 | 2017 | 2805 | 0.020 |
Why?
| | Reproducibility of Results | 1 | 2018 | 3287 | 0.020 |
Why?
| | Mice, Inbred C57BL | 1 | 2021 | 5764 | 0.020 |
Why?
| | Predictive Value of Tests | 1 | 2015 | 2017 | 0.020 |
Why?
| | Inservice Training | 1 | 2010 | 118 | 0.020 |
Why?
| | Problem Solving | 1 | 2010 | 155 | 0.020 |
Why?
| | Program Development | 1 | 2010 | 362 | 0.020 |
Why?
| | Signal Transduction | 1 | 2021 | 5060 | 0.020 |
Why?
| | Cooperative Behavior | 1 | 2010 | 457 | 0.020 |
Why?
| | Administration, Inhalation | 1 | 2008 | 590 | 0.020 |
Why?
| | Leadership | 1 | 2010 | 393 | 0.020 |
Why?
| | Risk | 1 | 2008 | 904 | 0.020 |
Why?
| | Cross-Sectional Studies | 1 | 2016 | 5507 | 0.010 |
Why?
| | Patient Care Team | 1 | 2010 | 634 | 0.010 |
Why?
| | Fractures, Bone | 1 | 2008 | 393 | 0.010 |
Why?
| | Infant, Newborn | 1 | 2013 | 6125 | 0.010 |
Why?
|
|
Murphy's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|